Cargando…
White blood cell concentration correlates with increased concentrations of IL-1ra and improvement in WOMAC pain scores in an open-label safety study of autologous protein solution
BACKGROUND: There has been debate on which blood components should be included in autologous therapies. Autologous Protein Solution (APS) is a unique blood-derived therapy composed of concentrated white blood cells, platelets, and plasma to contain high concentrations of anti-inflammatory cytokines...
Autores principales: | King, William, van der Weegen, Walter, Van Drumpt, Rogier, Soons, Hans, Toler, Krista, Woodell-May, Jennifer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4747972/ https://www.ncbi.nlm.nih.gov/pubmed/26915009 http://dx.doi.org/10.1186/s40634-016-0043-7 |
Ejemplares similares
-
Safety and Treatment Effectiveness of a Single Autologous Protein Solution Injection in Patients with Knee Osteoarthritis
por: van Drumpt, Rogier A.M., et al.
Publicado: (2016) -
Role of White Blood Cells in Blood- and Bone Marrow-Based Autologous Therapies
por: King, William, et al.
Publicado: (2018) -
An Autologous Anti-Inflammatory Protein Solution Yielded a Favorable Safety Profile and Significant Pain Relief in an Open-Label Pilot Study of Patients with Osteoarthritis
por: Hix, Jason, et al.
Publicado: (2017) -
The Role of PRP and Its Platelet Concentration in Improving WOMAC Score on
Early-Stage Knee Osteoarthritis (OA) Patients
por: Supartono, Basuki, et al.
Publicado: (2020) -
Potential Mechanism of Action of Current Point-of-Care Autologous Therapy Treatments for Osteoarthritis of the Knee—A Narrative Review
por: Woodell-May, Jennifer, et al.
Publicado: (2021)